Medplus Health Services Limited has announced its unaudited standalone and consolidated financial results for the quarter ended December 31, 2025. The Board of Directors approved these results on January 30, 2026. An extract of these results was published in The Financial Express and Nava Telangana on January 31, 2026. In addition to the financial results, the company has scheduled several important events. A board meeting is set for February 25, 2026, to discuss various proposals. Furthermore, Medplus Health Services Limited is organizing a shareholder meeting on March 27, 2026, with the results for the financial year 2025-26 to be declared. The meeting will also cover the approval of the annual audited financial statements for FY25-26 and the declaration of a dividend. The book closure for the dividend will be from March 28 to March 31, 2026. The company also announced a significant corporate action: a "scheme of arrangement" involving the demerger of its retail pharmacy business into a wholly-owned subsidiary, Medplus Wellness Limited. This scheme is subject to regulatory approvals and is expected to be completed by March 31, 2027. The rationale behind this demerger is to unlock value and enable focused growth for both the retail and wholesale businesses. The company believes this will create distinct strategic, operational, and financial flexibility for each entity.